Among BC treatments, endocrine therapy refers to the systematic use of aromatase inhibitor (AI) or oestrogen receptor (ER) modulators to reduce female hormone levels, inhibit ovarian function, and control tumour growth in female BC survivors who are ER-positive [5]. This evidence concerns the gene CYP19A1 and breast cancer.